Maili R. Bergman
Geen lopende functies
Profiel
Maili R.
Bergman worked as a Director of Investor Relations and Communications at Abraxis BioScience, Inc. from 2009 to 2011.
She also worked as a Director of Investor Relations at Allegro Biodiesel Corp.
and as a Vice President of Investor Relations at Guess?, Inc.
Eerdere bekende functies van Maili R. Bergman
| Bedrijven | Functie | Einde |
|---|---|---|
| GUESS?, INC. | Investor Relations Contact | 01-10-2011 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Public Communications Contact | 30-03-2011 |
Allegro Biodiesel Corp.
 Allegro Biodiesel Corp. Other Metals/MineralsNon-Energy Minerals Allegro Biodiesel Corp. produces and distributes biodiesel fuel. The company produces biodiesel fuel on a 320 acre site in Pollock, Louisiana. It sells blended and unblended forms with petroleum based diesel fuel. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GUESS?, INC. | Consumer Non-Durables |
| Bedrijven in privébezit | 2 |
|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Allegro Biodiesel Corp.
Allegro Biodiesel Corp. Other Metals/MineralsNon-Energy Minerals Allegro Biodiesel Corp. produces and distributes biodiesel fuel. The company produces biodiesel fuel on a 320 acre site in Pollock, Louisiana. It sells blended and unblended forms with petroleum based diesel fuel. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Non-Energy Minerals |
